Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
deals
4
×
investing
4
×
life sciences
national blog main
san francisco
4
×
san francisco blog main
4
×
san francisco top stories
startups
boston blog main
boston top stories
clinical trials
national top stories
10x genomics
alphabet
amgen
auris health
auris surgical robots
biotech ipos
broad institute of harvard and mit
brook byers
cancer
cancer drugs
charles chu
cobimetinib
crispr
crispr cas14
d1 capital partners
decheng capital
desmoid tumors
diagnostic
dihydroergotamine
frederic moll
generic drugs
google
infectious disease
intuitive surgical
ipo
kleiner perkins
lung cancer
What
ipo
auris
available
based
big
bio
biosciences
biotech
boost
cancer
cas
cheaper
clearance
companies
crispr
despite
develop
diagnostics
drug
expand
expects
family
faster
followed
funding
genomics
hardest
haul
health
help
hit
hottest
hunters
lands
led
life
lung
mammoth
markets
medical
Language
unset
Current search:
deals
×
" san francisco blog main "
×
" san francisco "
×
investing
×
@xconomy.com
4 years ago
Revolution Medicines IPO Reels In $238M to Take On RAS in Cancer
@xconomy.com
4 years ago
With $45M, Mammoth Bio Expects Big Things From Tiny CRISPR Cas14
@xconomy.com
4 years ago
SpringWorks and Satsuma Boost This Week’s Biotech IPO Haul to $595M
@xconomy.com
5 years ago
Auris Health Lands $220M to Expand Sales of Lung Testing Medical Robot
